Staphylococcus aureus can cause localized infections such as abscesses and pneumonia,
as well as systemic infections such as bacteremia and sepsis. Especially, methicillin …

In this work, we report the isolation and detailed functional characterization for the new non-
ribosomally synthesized antibiotic 5812-A/C, which was derived from metabolites of …

We report a novel family of natural lipoglycopeptides produced by Streptomyces sp. INA‐Ac‐
5812. Two major components of the mixture, named gausemycins A and B, were isolated …

Gausemycin A is the first member of the novel lipoglycopeptides family produced by
Streptomyces roseoflavus INA-Ac-5812. Gausemycin A has a pronounced bactericidal …

We report the molecular mechanism of action of gausemycins and the isolation of new
members of the family, gausemycins C (1c), D (1d), E (1e), and F (1f), the minor components …

The derivatization reagent was prepared in situ by the reaction of tris (2, 6-dimethoxyphenyl)
methylium hexafluorophosphate with N-(2-aminoethyl) maleimide and used for the …

Chloro-l-kynurenine (3-(4-chloroanthraniloyl)-l-alanine, l-4-ClKyn), an amino acid known as
a prospective antidepressant, was recently for the first time found in nature in the lipopeptide …

The antibiotics INA-5812, produced by the strain INA-Ac-5812 of Streptomyces roseoflavus
have pronounced antibacterial and chemotherapeutic activity and low value of acute toxicity …

Three natural glycosylated macrolide compounds, known irumamycin 1 and X-14952B 2, as
well as new isoirumamycin 3, were isolated from ethyl acetate mycelium extract of …

Gausemycins A and B are the first members of the novel lipoglycopeptides family produced
by Streptomyces roseoflavus INA-Ac-5812, which showed the ability to fight clinically …